The acute effect of smoking on systemic haemodynamics, kidney and endothelial functions in insulin-dependent diabetic patients with micro albuminuria

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 56, Issue 5, 1996, Pages 393-399

  Hansen, H P ^a   Rossing, K ^a   Jacobsen, P ^a   Jensen, B R ^a   Parving, H H ^a  

^a STENO DIABETES CENTER   (Denmark)

Author keywords

Arterial blood pressure; Cigarette smoking; Glomerular filtration rate; Transcapillary escape rate of albumin urinary albumin excretion; Von Willebrand factor

Indexed keywords

INSULIN;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; GLOMERULUS FILTRATION RATE; HEART RATE; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MICROALBUMINURIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING;

EID: 0029814629     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365519609088793     Document Type: Article

References (42)

1. Deckert T, Poulsen JE, Larsen M. Prognosis of diabetics with diabetes onset before the age of thirty-one. I. Survival, causes of death and complications. Diabetologia 1978; 14: 363-70.
2. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T. Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 1983; 25: 496-501.
3. Christiansen JS. Cigarette smoking and prevalence of microangiopathy in juvenile-onset insulin-dependent diabetes mellitus. Diabetes Care 1978; 1: 146-9.
4. Nordén G, Nyberg G. Smoking and diabetic nephropathy. Acta Med Scand 1984; 215: 257-61.
5. Mühlhauser I, Sawicki PT, Berger M. Cigarette smoking as a risk factor for macroproteinuria and proliferative retinopathy in Type 1 (insulin-dependent) diabetes. Diabetologia 1986; 29: 500-2.
6. Chase HP, Garg SK, Marshall G, Berg CL, Harris S, Jackson WE, et al. Cigarette smoking increases the risk of albuminuria among subjects with type 1 diabetes. J Am Med Assoc 1991; 265: 614-7.
7. Sawicki PT, Didjurgeit U, Mühlhauser I, Bender R, Heinemann L, et al. Smoking is associated with progression of diabetic nephropathy. Diabetes Care 1994; 17: 126-31.
8. Jensen EW, Andersen HB, Nielsen SL, Christensen NJ. Long-term smoking increases transcapillary escape rate of albumin. Scand J Clin Lab Invest 1992; 52: 653-6.
9. Nielsen FS, Rossing P, Bang LE, et al. Endothelial dysfunction in NIDDM patients with and without diabetic nephropathy [abstract]. J Am Soc Nephrol 1994; 5: 16P.
10. Remuzzi G, Bertani T. Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 1990; 38: 384-94.
11. Parving H-H. The effect of hypoxia and carbon monoxide exposure on plasma volume and capillary permeability to albumin. Scand J Clin Lab Invest 1972; 30: 49-56.
12. Lin S-J, Hong C-Y, Chang M-S, Chiang BN, Chien S. Long-term nicotine exposure increases aortic endothelial cell death and enhances transendothelial macromolecular transport in rats. Arterioscler Thromb 1992; 12: 1305-12.
13. Groppelli A, Giorgi DMA, Omboni S, Parati G, Mancia G. Persistent blood pressure increase induced by heavy smoking. J Hypertens 1992; 10: 495-9.
14. Hostetter TH, Rennke HG, Brenner BM. The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 1982; 72: 375-80.
15. Brenner BM. Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int 1983; 23: 647-55.
16. Zatz R, Brenner BM. Pathogenesis of diabetic microangiopathy. The hemodynamic view. Am J Med 1986; 80: 443-53.
17. Anderson S, Brenner BM. Pathogenesis of diabetic glomerulopathy: Hemodynamic considerations. Diabetes Metab Rev 1988; 4: 163-77.
18. Tarnow L, Rossing P, Gall M-A, Nielsen FS, Parving H-H. Prevalence of arterial hypertension in diabetic patients before and after the JNC-V. Diabetes Care 1994; 17 (11): 1247-51.
19. White WB, Pickering TG, Morganroth J, James GD, McCabe EJ, Moucha O, et al. A multicenter evaluation of the A&D TM-2420 ambulatory blood pressure recorder. Am J Hypertens 1991; 4: 890-6.
20. Jamieson MJ, Fowler G, MacDonald TM, Webster J, Witte K, Lawson L, et al. Bench and ambulatory field evaluation of the A&D TM-2420 automated sphygmomanometer. J Hypertens 1990; 8: 599-605.
21. Høegholm A, Eidemark I, Kristensen KS, Bang LE, Madsen NH. Clinical evaluation of the Takeda Medical (A&D) TM 2420 ambulatory blood pressure monitor. Practical experience and comparison with direct and indirect measurements. Scand J Clin Lab Invest 1992; 52: 261-8.
22. Clark S, Fowlie S, Coats A, Radaelli A, van der Putt M, Bird R, et al. Ambulatory blood pressure monitoring: validation of the accuracy and reliability of the TM-2420 according to the AAMI recommendations. J Hum Hypertens 1991; 5: 77-82.
23. Parving H-H, Gyntelberg F. Transcapillary escape rate of albumin and plasma volume in essential hypertension. Circ Res 1973; 32: 643-51.
24. Parving H-H, Rossing N, Nielsen SL, Lassen NA. Increased transcapillary escape rate of albumin, IgG and IgM after plasma volume expansion. Am J Physiol 1974; 227: 245-50.
25. Brøchner-Mortensen J, Rødbro P. Selection of routine method for determination of glomerular filtration rate in adult patients. Scand J Clin Lab Invest 1976; 36: 35-45.
26. Brøchner-Mortensen J. A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 1972; 30: 271-4.
27. Feldt-Rasmussen B, Dinesen B, Deckert M. Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand J Clin Lab Invest 1985; 45: 539-44.
28. Ingerslev J. A sensitive ELISA for von Willebrand factor (vWF:Ag). Scand J Clin Lab Invest 1987; 47: 143-9.
29. Cryer PE, Haymond MW, Santiago JV, Shah SD. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med 1976; 295: 573-7.
30. Trap-Jensen J, Carlsen JE, Svendsen TL, Christensen NJ. Cardiovascular and adrenergic effects of cigarette smoking during immediate non-selective and selective beta adrenoceptor blockade in humans. Eur J Clin Invest 1979; 9: 181-3.
31. Baer L, Radichevich I. Cigarette smoking in hypertensive patients. Am J Med 1985; 78: 564-8.
32. 1 inhibition. J Hypertens 1990; 8: S35-40.
33. Hommel E, Mathiesen ER, Edsberg B, Bahnsen M, Parving H-H. Acute reduction of arterial blood pressure reduces urinary albumin excretion in type 1 (insulin-dependent) diabetic patients with incipient nephropathy. Diabetologia 1986; 29: 211-5.
34. Parving H-H, Kastrup J, Smidt UM, Andersen AR, Feldt-Rasmussen B, Christiansen JS. Impaired autoregulation of glomerular filtration rate in Type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia 1984; 27: 547-52.
35. Mühlhauser I. Smoking and diabetes. Diabetic Med 1990; 7: 10-5.
36. Parving H-H. Microvascular permeability to plasma proteins in hypertension and diabetes mellitus in man - on the pathogenesis of hypertensive and diabetic microangiopathy. Dan Med Bull 1975; 22: 217-33.
37. Lassen NA, Parving H-H, Rossing N. Filtration as the main mechanism of overall transcapillary protein escape from the plasma. Microvasc Res 1974; 7: 1-4.
38. Parving H-H, Kastrup J, Smidt UM. Reduced transcapillary escape rate of albumin during acute blood pressure-lowering in type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia 1985; 28: 797-801.
39. Parving H-H, Rasmussen SM. Transcapillary escape rate of albumin and plasma volume in short- and long-term juvenile diabetics. Scand J Clin Lab Invest 1973; 32: 81-7.
40. Feldt-Rasmussen B. Increased transcapillary escape rate of albumin in Type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 1986; 29: 282-6.
41. Parving H-H. Impact of blood pressure and antihypertensive treatment on incipient and overt nephropathy, retinopathy, and endothelial permeability in diabetes mellitus. Diabetes Care 1991; 14: 260-9.
42. Parving H-H, Smidt UM. Hypotensive therapy reduces microvascular albumin leakage in insulin-dependent diabetic patients with nephropathy. Diabetic Med 1986; 3: 312-5.